(19)
(11) EP 2 099 438 A2

(12)

(88) Date of publication A3:
18.12.2008

(43) Date of publication:
16.09.2009 Bulletin 2009/38

(21) Application number: 07772782.4

(22) Date of filing: 14.03.2007
(51) International Patent Classification (IPC): 
A61K 31/00(2006.01)
C07H 21/00(2006.01)
A61K 31/713(2006.01)
(86) International application number:
PCT/US2007/006371
(87) International publication number:
WO 2008/088358 (24.07.2008 Gazette 2008/30)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30) Priority: 08.01.2007 US 650478
08.01.2007 US 650479
13.03.2007 US 685474

(71) Applicant: Biovec LLC
Chicago, IL 60611 (US)

(72) Inventors:
  • SEHGAL, Lakshman, R.
    Monarch Beach, CA 92629-4105 (US)
  • WONG, Jonathan
    Palo Alto, CA 94303 (US)

(74) Representative: Brand, Thomas Louis 
W.P. Thompson & Co. 55 Drury Lane
London WC2B 5SQ
London WC2B 5SQ (GB)

   


(54) EX VIVO AND IN VIVO EXPRESSION OF THE THROMBOMODULIN GENE FOR THE TREATMENT OF CARDIOVASCULAR AND PERIPHERAL VASCULAR DISEASES